Authors: Nyronen, T Pihlavisto, M Peltonen, JM Hoffren, AM Varis, M Salminen, T Wurster, S Marjamaki, A Kanerva, L Katainen, E Laaksonen, L Savola, JM Scheinin, M Johnson, MS

Citation: T. Nyronen et al., Molecular mechanism for agonist-promoted alpha(2A)-adrenoceptor activationby norepinephrine and epinephrine, MOLEC PHARM, 59(5), 2001, pp. 1343-1354

Authors: Cockcroft, V Frang, H Pihlavisto, M Marjamaki, A Scheinin, M

Citation: V. Cockcroft et al., Ligand recognition of serine-cysteine amino acid exchanges in transmembrane domain 5 of alpha(2)-adrenergic receptors by UK 14,304, J NEUROCHEM, 74(4), 2000, pp. 1705-1710

Authors: Salminen, T Varis, M Nyronen, T Pihlavisto, M Hoffren, AM Lonnberg, T Marjamaki, A Frang, H Savola, JM Scheinin, M Johnson, MS

Citation: T. Salminen et al., Three-dimensional models of alpha(2A)-adrenergic receptor complexes provide a structural explanation for ligand binding, J BIOL CHEM, 274(33), 1999, pp. 23405-23413

Authors: Marjamaki, A Frang, H Pihlavisto, M Hoffren, AM Salminen, T Johnson, MS Kallio, J Javitch, JA Scheinin, M

Citation: A. Marjamaki et al., Chloroethylclonidine and 2-aminoethyl methanethiosulfonate recognize two different conformations of the human alpha(2A)-adrenergic receptor, J BIOL CHEM, 274(31), 1999, pp. 21867-21872

Authors: Pihlavisto, M Scheinin, M

Citation: M. Pihlavisto et M. Scheinin, Functional assessment of recombinant human alpha(2)-adrenoceptor subtypes with Cytosensor microphysiometry, EUR J PHARM, 385(2-3), 1999, pp. 247-253